Answers are grounded in this paper and cite their sources.
Background: Rubella is a mild illness with most cases goes undiagnosed because of its sub clinical nature. However, the disease poses serious threat such as congenital rubella defects, abortions, and still birth if a pregnant woman contracted the infection during her first trimester. Unfortunately lack of sufficient data on its prevalence and incidence with unavailability of rubella vaccines in our antenatal clinics is of great dangers to our sero-negative women with their unborn babies. Objective: To determine the sero-prevalence of rubella IgG within the two Nigerian communities. Methods: Two hundred and sixty seven (267) pregnant women attending antenatal clinics in Mangu and Pankshin General Hospital and Primary Health Care (PHC) Clinics were screened for Rubella IgG using ELISA Test kit (Globalemed, Alexandria VA USA) based on the manufacturer’s instructions. Questionnaires were also used to obtain other vital bio-data of patients and results analyzed using SPSS version, 13.0 statistical software package. Results: Out of all the samples screened, 247(92.51%) were seropositive for rubella IgG. Rubella IgG was detected in all age groups and occupational status considered and the results indicated a significant relation with the presence of the antibody (P<0.05). So also, Rubella IgG was also detected from all the different parity groups, some socio-cultural variables, probable clinical manifestations and location. However, the results indicated that there were no significant relationships between the presence of the antibody with these variables (P>0.05).Conclusion: This work indicates that most of the women screened (92.51%) were already immune due to natural exposure to the virus. The remaining 7.49% needs to be protected from being infected with the virus especially during the first trimester of pregnancy which can result to congenital defects with fatal consequences. As such, there is need for more sero-surveys on rubella in the country to support the advocacy for the inclusion of rubella vaccination in the National Programme on Immunization (NPI).
No takes yet. Share an insight, caveat, or question.
Bigwan Emmanuel Isa (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: